Scientific Opportunities with a Rare-Isotope Facility in the United States (2007) / Chapter Skim
Currently Skimming:
Appendix E: Additional Remark on Clinical Use of Rare Iisotopes
Appendix E: Additional Remark on Clinical Use of Rare Iisotopes
Pages 129-131
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 129... ...
E Additional Remark on Clinical Use of Rare Isotopes T he medical community continues to investigate new isotopes for use in radiation therapy. Recently, studies of the rare isotope 149Tb (terbium)
|
From page 130... ...
SCIENTIFIC OPPORTUNITIES RARE-ISOTOPE FACILITY 130 WITH A FIGURE E.1 Survival plot of mice grafted with 5 × 106 Daudi cells followed by different intravenous treatments 2 days subsequent. From European Journal of Nuclear Medicine and Molecular Imaging ˇ 31(4)
|
From page 131... ...
APPENDIX E 131 The mice were separated into 4 groups: 6 received no further injection (control group) , 6 received 5 µg of rituximab, 4 received 300 µg of rituximab, and 10 received 5 µg of rituximab labeled with radioactive 149Tb with a decay rate of 5.5 × 106 decays per second.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.